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OBJECTIVEdTo determine the extent of, and reasons for, ethnic differences in type 2 diabetes
incidence in the U.K.
RESEARCH DESIGN AND METHODSdPopulation-based triethnic cohort. Partici-
pants were without diabetes, aged 40–69 at baseline (1989–1991), and followed-up for 20 years.
Baseline measurements included fasting and postglucose bloods, anthropometry, and lifestyle
questionnaire. Incident diabetes was identiﬁed from medical records and participant recall.
Ethnic differences in diabetes incidence were examined using competing risks regression.
RESULTSdIncident diabetes was identiﬁed in 196 of 1,354 (14%) Europeans, 282 of 839
(34%) Indian Asians, and 100 of 335 (30%) African Caribbeans. All Indian Asians and African
Caribbeans were ﬁrst-generation migrants. Compared with Europeans, age-adjusted subhazard
ratios (SHRs [95% CI]) for men and women, respectively, were 2.88 (95%, 2.36–3.53; P, 0.001)
and 1.91 (1.18–3.10; P = 0.008) in Indian Asians, and 2.23 (1.64–3.03; P , 0.001) and 2.51
(1.63–3.87; P , 0.001) in African Caribbeans. Differences in baseline insulin resistance and
truncal obesity largely attenuated the ethnic minority excess in women (adjusted SHRs: Indian
Asians 0.77 [0.49–1.42]; P = 0.3; African Caribbeans 1.48 [0.89–2.45]; P = 0.13), but not in men
(adjusted SHRs: Indian Asians 1.98 [1.52–2.58]; P, 0.001 and African Caribbeans, 2.05 [1.46–
2.89; P , 0.001]).
CONCLUSIONSdInsulin resistance and truncal obesity account for the twofold excess in-
cidence of diabetes in Indian Asian and African Caribbean women, but not men. Explanations for
the excess diabetes risk in ethnic minority men remains unclear. Further study requires more
precise measures of conventional risk factors and identiﬁcation of novel risk factors.
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The global prevalence of type 2 di-abetes continues to increase, withthe Indian subcontinent predicted
to contribute the greatest increase in the
number of people with diabetes by 2030
(1). Indian Asian migrant populations
also experience greater prevalence of di-
abetes than host white populations (2,3).
Although prevalence of diabetes in sub-
Saharan Africa remains low, the preva-
lence in African-origin populations in
other areas of the world is elevated com-
pared with that of white populations
(4,5). Few studies have explored expla-
nations for ethnic differences in diabetes
incidence. The Atherosclerosis Risk in
Communities (ARIC) study found that al-
though adiposity, lifestyle, and socioeco-
nomic factors accounted for nearly 50%
of the excess diabetes risk in African
American women, none of the excess
could be explained in men (6), echoing
ﬁndings from the National Health and
Nutrition Examination Survey (NHANES)
(7,8). However, previous studies did not
explore the role of insulin resistance and
ectopic fat distribution. Further, there are
no longitudinal studies to explain the ex-
cess diabetes risk in Indian Asians com-
pared with Europeans.
We have reported a threefold preva-
lence of diabetes in men and women aged
40–70 years of Indian Asian and African
Caribbean origin compared with Europe-
ans in the SABRE (Southall And Brent
REvisited) cohort.Wenow report incidence
of diabetes and potential explanations for
ethnic differences in incidence in this
unique cohort with a 20-year follow-up to
ages 60–89 years.
RESEARCH DESIGN AND
METHODSdSABRE is a community-
based cohort of Europeans, Indian Asians,
and African Caribbeans from north and
west London. Details of the cohort have
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been published (9). Participants aged 40–
69 years at baseline (1988–1991) were ran-
domly selected from age- and sex-stratiﬁed
primary care physician lists (n = 4,063) and
workplaces (n = 795) in the London dis-
tricts of Southall and Brent (Fig. 1). Because
primary care registration is free and the
gateway to all health services in the U.K.,
this forms a representative and compre-
hensive sampling frame. The study was
designed to investigate cardiometabolic
risk in different ethnic groups, primarily
in men.
All Indian Asians and African Carib-
beans were ﬁrst-generation migrants.
Ethnicity was interviewer-recorded
based on parental origins and appear-
ance and was subsequently conﬁrmed
by participants. Indian Asians originated
from the Indian subcontinent. African
Caribbeans originated from the Carib-
bean (91.5%) or from West Africa. At
baseline, participants underwent fasting
blood tests, blood pressure measure-
ments, and anthropometry, and com-
pleted a health and lifestyle questionnaire.
Those whose diabetes status was unknown
underwent oral glucose tolerance testing
(OGTT).
During 2008–2011, survivors were
invited to participate in a morbidity follow-
up, including a health and lifestyle ques-
tionnaire, primary care medical record
review, and/or attendance at clinic at St.
Mary’s Hospital, London. Clinic attend-
ees fasted overnight and underwent
measurements as at baseline, including
OGTT.
All participants gave written in-
formed consent. Approval for the baseline
study was obtained from Ealing, Houns-
low and Spelthorne, Parkside, and Uni-
versity College London research ethics
committees, and at follow-up from
St. Mary’s Hospital Research Ethics Com-
mittee (reference 07/H0712/109).
Identifying baseline and incident
diabetes
Physician diagnosis or World Health
Organization 1999 criteria (10) for fast-
ing and OGTT blood glucose mea-
surements deﬁned baseline diabetes.
Incident diabetes was identiﬁed from a
positive report from one of the following
sources:
Direct follow-up:
Primary care medical record review: re-
corded diagnosis of diabetes or pre-
scription of antidiabetic medications.
Participant questionnaire: recall of physician-
diagnosed diabetes plus either year
of diagnosis or receipt of named anti-
diabetic medication.
Clinical follow-up at 20 years: fasting or
OGTT plasma glucose results meeting
World Health Organization 1999 cri-
teria (10). Plasma glucose was mea-
sured using hexokinase/NADP methods
(Abbott Diagnostics).
Indirect follow-up:
Hospital episode statistics (HES) or death
certiﬁcates: diagnosis of diabetes at
hospital discharge or diabetes listed as
an underlying or contributory cause of
death (ICD9 codes: 2500–2509; ICD10
codes: E100-E149) for sensitivity anal-
yses only.
Age at diagnosis was identiﬁed at ﬁrst
report of diabetes in primary care medical
Figure 1dFollow-up of SABRE cohort, 1988–2011.
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records or age at follow-up for the 86
(15%) cases identiﬁed at follow-up clinic.
Baseline risk factor measurements
Height was measured using a stadiome-
ter. Body fat included circumferences
around the waist (halfway between costal
margin and iliac crest), hip (over greater
trochanter), and midthigh, and was mea-
sured using a ﬁberglass tape with a spring
balance set to a constant tension of 600 g.
Holtain Harpenden calipers were used
to standard protocol to measure skinfold
thicknesses. Subcutaneous truncal fat was
estimated by addition of subscapular and
suprailiac skinfold thicknesses.
For OGTT, plasma glucose and in-
sulin were measured 2 h after 75 g oral
glucose (9). Blood was analyzed at the
same hospital laboratory (5). Glycated
hemoglobin was measured in stored
blood samples (Southall center only) us-
ing an immunoassay on a clinically vali-
dated automated analyzer (c311; Roche,
Burgess Hill, U.K.); the high and low
quality-control coefﬁcients of variation
were 2.9 and 3.3%. Baseline insulin resis-
tance (IR) as a measure of hepatic IR and
percentage b-cell function (HOMA2-B)
were approximated using the HOMA2
calculator (11). The formula derived by
Matsuda et al. (12) incorporates both fast-
ing and postload measures, thus approx-
imating both hepatic and peripheral IR
(!(fasting glucose3 2-h glucose[mg/dL]3
fasting insulin 3 2 h insulin [mU/mL])/
10,000).
Sitting blood pressure was the mean
of two resting measurements using a ran-
dom zero sphygmomanometer (Hawksley,
Lancing, U.K.).
Physical activity was assessed by ques-
tionnaire. Methods based on the Allied
Dunbar Fitness survey (13) were used to
calculate energy expenditure for leisure ac-
tivity, giving a summary estimate of total
weekly energy expenditure (MJ) in sport,
walking, cycling, and strenuous activities.
An index of physical activity at work was
generated (Supplementary Data).
Statistical analyses
Primary analyses relate to data obtained
from direct follow-up sources for people
without baseline diabetes. Indirect data
(HES) and death certiﬁcation data were
not used for primary analyses because
date of diagnosis could not be established.
We amalgamated direct data sources to
identify incident diabetes and found no
evidence of heterogeneity between sources
using a meta-analysis approach. Baseline
characteristics by incident diabetes status
were compared using parametric (Student t)
or nonparametric (Wilcoxon rank sum/x2)
tests, as appropriate.
Competing risks regression (compet-
ing risk = death) based on Fine and Gray
proportional subhazards methods (14)
was used to describe ethnic differences
in diabetes incidence and to examine
baseline characteristics representing a se-
ries of prespeciﬁed parameters (anthro-
pometric, metabolic, blood pressure,
lifestyle, socioeconomic position) as pre-
dictors of incident diabetes in univariate
models. Those predictors that most sub-
stantially and signiﬁcantly altered the
subhazard ratio (SHR) for ethnic differ-
ence were included in multivariate mod-
els. Interactions between ethnicity and
baseline risk factors chosen for multivar-
iate models were examined.
We tested interactions between follow-
up time and each covariate. The small
number of covariates in which the pro-
portional hazards assumption was violated
was included as time-varying covariates.
We plotted cumulative incidence curves
for each ethnic–sex group and examined
Schoenfeld-like residuals. All analyses are
stratiﬁed by ethnicity and sex. We re-
peated analyses of associations between
baseline risk factors and ethnicity using
logistic regression combining HES, death
certiﬁcate, and directly collected data. All
analyses were conducted in STATA
version 12. All statistical tests were two-
sided and statistical signiﬁcance was ac-
cepted as P , 0.05.
RESULTSdOf those without baseline
diabetes (N = 4,202), 3,908 (93%) were
traced to a U.K. address. Direct follow-up
data were available for 1,354 (66%), 839
(65%), and 335 (61%) of traced Europe-
ans, Indian Asians, and African Carib-
beans, respectively. Proportions with
any follow-up data increased to 91, 87,
and 92% of traced Europeans, Indian
Asians, and African Caribbeans when
HES and deaths data were included
(Fig. 1).
Diabetes developed in 14% of Euro-
peans, 33% of Indian Asians, and 30% of
African Caribbeans between baseline
(mean age, 51.8 6 7.0 years) and
follow-up (mean age, 70.5 6 6.3 years).
Cumulative incidence by age at follow-up
is illustrated (Fig. 2).
Diabetes risk and determinants
in men
Indian Asians who had development of
diabetes had lower BMI at baseline but
were more centrally obese than Europe-
ans (Table 1). Although baseline fasting
and postload glucose did not differ, In-
dian Asians had higher fasting insulin,
more adverse measures of insulin resis-
tance, and higher calculated b-cell func-
tion than Europeans. In contrast, only the
Figure 2dCumulative incidence of diabetes during 20 years of follow-up.
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Ethnicity and incident diabetes
Matsuda IR index was elevated in African
Caribbeans compared with Europeans.
Fasting insulin and estimated b-cell func-
tion were lowest and fasting and postload
glucose were highest in African Carib-
beans who had development of diabetes
(Table 1). Fasting HDL cholesterol was
lower and triglyceride levels were higher
in Europeans and Indian Asians who had
development of diabetes. Leisure time en-
ergy expenditure was lower in Indian
Asians and African Caribbeans regardless
of diabetes status. African Caribbeans
who had development of diabetes were
also less active at work than Europeans.
Smoking predicted diabetes incidence in
European and Indian Asian men.
Indian Asian men were nearly three
times more likely to have development of
diabetes than European men (Table 2)
and were younger at diagnosis (median,
62 vs. 67 years; P , 0.001). Adjustment
for baseline smoking increased the SHR
for Indian Asians versus Europeans to
3.37 (95% CI, 2.67–4.26; P , 0.001).
The Matsuda index of IR most attenuated,
but did not abolish, the Indian Asian
excess risk of diabetes (adjusted SHR,
2.16; 95% CI, 1.68–2.78; P , 0.001).
Multivariate adjustment slightly further
attenuated the ethnic differential (SHR,
1.98; 95% CI, 1.52–2.58; P , 0.001)
truncal obesity and Matsuda IR were
Table 2dEthnic group differences in incidence of diabetes adjusted for baseline risk factors
Indian Asians vs. Europeans African Caribbeans vs. Europeans
All men
Unadjusted 2.82 (2.29–3.46), P , 0.001 2.46 (1.79–3.37), P , 0.001
Adjusted for age 2.88 (2.36–3.53), P , 0.001 2.23 (1.64–3.03), P , 0.001
Adjusted for age and smoking 3.37 (2.67–4.26), P , 0.001 2.27 (1.66–3.11), P , 0.001
Adjusted for age, smoking, and years of education 3.55 (2.79–4.52), P , 0.001 2.34 (1.71–3.21), P , 0.001
Adjusted for age, smoking, and physical activity
(leisure time and work group) 3.37 (2.64–4.31), P , 0.001 2.33 (1.69–3.21), P , 0.001
Adjusted for age, smoking, and BMI 3.59 (2.83–4.56), P , 0.001 2.19 (1.60–3.00), P , 0.001
Adjusted for age, smoking, and waist-to-height ratio 2.98 (2.35–3.79), P , 0.001 2.43 (1.78–3.33), P , 0.001
Adjusted for age, smoking, and height 3.42 (2.67–4.38), P , 0.001 2.26 (1.64–3.10), P , 0.001
Adjusted for age, smoking, height, and truncal
skinfold thickness 2.82 (2.20–3.60), P , 0.001 1.84 (1.31–2.58), P , 0.001
Adjusted for age, smoking, height, and waist-to-hip ratio 2.70 (2.10–3.49), P , 0.001 2.38 (1.73–3.26), P , 0.001
Adjusted for age, smoking, fasting, and postload glucose/insulin 2.36 (1.83–3.05), P , 0.001 1.96 (1.44–2.68), P , 0.001
Adjusted for age, smoking, and Matsuda index of IR 2.16 (1.68–2.78), P , 0.001 1.98 (1.45–2.69), P , 0.001
Adjusted for age, smoking, and HOMA2-IR 2.64 (2.06–3.38), P , 0.001 2.28 (1.66–3.12), P , 0.001
Adjusted for age, smoking, and HOMA2-B 3.08 (2.41–3.94), P , 0.001 2.40 (1.74–3.30), P , 0.001
Adjusted for age, smoking and HDL cholesterol 3.15 (2.47–4.01), P , 0.001 2.52 (1.80–3.55), P , 0.001
Adjusted for age, smoking and triglycerides 2.99 (2.34–3.83), P , 0.001 2.98 (2.13–4.16), P , 0.001
Adjusted for age, smoking, Matsuda index of IR, HDL
cholesterol, waist-to-hip ratio, and truncal skinfold thickness 1.98 (1.52–2.58), P , 0.001 d
Adjusted for age, smoking, Matsuda index of IR, triglycerides,
and truncal skinfold thickness d 2.28 (1.61–3.21), P , 0.001
All women
Unadjusted 1.62 (1.00–2.61), P = 0.049 2.62 (1.70–4.03), P , 0.001
Adjusted for age 1.91 (1.18–3.10), P = 0.008 2.51 (1.63–3.87), P , 0.001
Adjusted for age and years of education 1.80 (1.05–3.08), P = 0.032 2.51 (1.63–3.87), P , 0.001
Adjusted for age and physical activity (leisure time and work group) 1.94 (1.16–3.24), P = 0.011 2.33 (1.51–3.60), P , 0.001
Adjusted for age and BMI 1.71 (1.05–2.78), P = 0.030 1.75 (1.12–2.74), P = 0.014
Adjusted for age and waist-to-height ratio 1.33 (0.80–2.19), P = 0.27 1.74 (1.13–2.68), P = 0.012
Adjusted for age and height 2.23 (1.29–3.86), P = 0.004 2.52 (1.64–3.88), P , 0.001
Adjusted for age, height, and truncal skinfold thickness 1.08 (0.61–1.89), P = 0.79 1.78 (1.15–2.75), P = 0.009
Adjusted for age, height, and waist-to-hip ratio 1.88 (1.07–3.30), P = 0.029 1.86 (1.21–2.87), P = 0.005
Adjusted for age, fasting, and postload glucose/insulin 1.67 (0.92–3.01), P = 0.090 1.46 (0.89–2.40), P = 0.139
Adjusted for age and Matsuda index of IR 1.11 (0.67–1.83), P = 1.00 1.35 (0.84–2.16), P = 0.22
Adjusted for age and HOMA2-IR 1.52 (0.93–2.48), P = 0.096 1.60 (0.98–2.60), P = 0.060
Adjusted for age and HOMA2-B 1.72 (1.00–2.98), P = 0.052 2.23 (1.36–3.65), P = 0.002
Adjusted for age and HDL cholesterol 1.66 (1.01–2.72), P = 0.045 2.43 (1.56–3.78), P , 0.001
Adjusted for age and triglycerides 1.84 (1.13–2.99), P = 0.014 3.03 (1.93–4.75), P , 0.001
Adjusted for age, waist-to-height ratio, Matsuda index
of IR, HDL cholesterol, and truncal skinfold thickness 0.77 (0.49–1.42), P = 0.34 d
Adjusted for age, waist-to-height ratio, and Matsuda
index of IR, triglycerides d 1.48 (0.89–2.45), P = 0.130
SHR (95% Cl) derived from competing risks proportional hazards regression (death = competing risk).
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independent predictors (P, 0.05) (Table
2). Data on baseline HbA1c were available
for 70% of Europeans and 77% of Indian
Asians; that inclusion in the multivariable
model did not explain ethnic differences
in diabetes incidence (not shown).
Although only available for 2,011
surviving participants who completed
follow-up questionnaires, family history
of diabetes was more prevalent in ethnic
minority groups and most prevalent in
those with incident diabetes. (Table 1).
For this subgroup, ethnic differentials in
diabetes incidence were similar to those of
the whole group (age-adjusted SHR, 2.79;
95%CI, 2.22–3.51; P, 0.001). A positive
family history independently accounted
for a small part of the excess diabetes risk
in Indian Asians when added to the mul-
tivariate model (family history-adjusted
SHR, 1.82; 95% CI, 1.1.33–2.49, and P ,
0.001 vs. 2.03; 95%CI, 1.48–2.77, andP,
0.001 when family history was not in-
cluded).
African Caribbean men, whether of
West African or Caribbean descent, had
twice the incidence of diabetes compared
with Europeanmen, althoughmedian age
at diagnosis was similar (median, 68 vs.
67 years; P = 0.51). Because African Ca-
ribbean men were less centrally obese and
had more favorable lipids than European
men, adjustment for these factors exag-
gerated the ethnic difference in diabetes
incidence. Adjustment for truncal skin-
folds attenuated the ethnic difference
(SHR, 1.84; 95% CI, 1.31–2.58; P ,
0.001). Adjustment for Matsuda IR or its
components provided the next greatest
attenuation, bringing the SHR to 1.98 or
1.96 (P , 0.001). Further multivariate
adjustment or adjustment for family his-
tory provided no additional attenuation
(Table 2).
Diabetes risk and determinants in
women
Patterns for women were similar to those
for men with the following exceptions
(Table 1). African Caribbean women were
the most centrally obese. The sex differ-
ence in truncal skinfolds differed mark-
edly by ethnicity in those who had
development of diabetes. Baseline truncal
skinfold was 0.6 cm greater in European
women than in European men, but 2.4
cm greater in Indian Asian women and
1.4 cm greater in African Caribbean
women than in men of the same ethnici-
ties. Fasting insulin and HOMA-IR were
highest in African Caribbean women and
lowest in European women. Asian
Indians and African Caribbeans had sim-
ilarly elevated levels of Matsuda IR com-
pared with Europeans. Fasting HDL
cholesterol was lower and triglycerides
were higher in European and African Ca-
ribbean women who later had develop-
ment of diabetes, whereas there was no
signiﬁcant diabetes-related difference in
lipid proﬁles in Indian Asian women. Lei-
sure time physical activity was lowest in
Indian Asian women, whereas African Ca-
ribbean and Indian Asian women were
more active at work, regardless of diabetes
status. Age at diagnosis of diabetes did not
differ by ethnicity in women.
The ethnic differential in incident
diabetes was less marked between Indian
Asian and European women and disap-
peared on adjustment for truncal skinfold
thickness (adjusted SHR, 1.08; 95% CI,
0.61–1.89; P = 0.79). Waist-to-height ra-
tio and Matsuda IR also had a similarly
marked attenuating effect (Table 2).
Only truncal skinfold thickness (P =
0.041) and Matsuda IR (P , 0.001)
were independent predictors.
African Caribbean women were 2.5
times more likely to have development of
diabetes than European women. Adjust-
ment for truncal or abdominal obesity
partially attenuated the ethnic differen-
tial, but the Matsuda IR index had the
greatest attenuating effect. In the multi-
variable model, the SHR was 1.48 (95%
CI, 0.89–2.45) (Table 2). Only Matsuda
IR (P , 0.001) and waist-to-height ratio
(P = 0.016) were independent predictors.
No other baseline risk factor, includ-
ing family history, physical activity, so-
cioeconomic markers, medication use,
and age at migration, further altered the
excess diabetes risk in men and women of
either ethnicity.
Sensitivity analyses
Hospital discharge (HES) data, based on
2,996 people without baseline diabetes,
demonstrated incident diabetes in 11 and
8% of European men and women, 26 and
14% of Indian Asian men and women,
and 21 and 15% of African Caribbean
men and women. Findings from analyses
of ethnic group differences in diabetes
incidence were similar when we used
logistic regression to compare HES data
added to direct follow-up (n = 3,679) ver-
sus direct follow-up alone.
Smoking was unusual in Indian Asian
and African Caribbean women; however,
these analyses repeated in never-smoking
women demonstrated similar ethnic dif-
ferentials.
CONCLUSIONSdIn this British
population-based triethnic cohort with
more than 20 years of follow-up, diabetes
incidence is substantially elevated in peo-
ple of African Caribbean and Indian Asian
origin compared with Europeans. By age
80, 40–50% of British Indian Asian and
African Caribbean men and women have
diabetes, at least twice the prevalence ob-
served in Europeans of the same age. Mid-
life measures of IR and of upper body fat
deposition were already unfavorable in
people who had development of diabetes
approximately one decade later and were
more adverse in the ethnic minorities.
The Matsuda IR index contributed most
to explaining the ethnic minority excess
of diabetes in both sexes. Of obesity mea-
sures, adjustment for truncal fat provided
the most consistent and independent at-
tenuation of the ethnic differentials in
both sexes Adjustment for these risk fac-
tors in women largely abolished the eth-
nic minority difference in diabetes
incidence. Inmen, however, a twofold ex-
cess remained for both ethnic minority
groups. ARIC (6) and NHANES (7,8)
both suggest that their available lifestyle
and adiposity measures could determine
some of the African American excess in
diabetes in women, but not in men. How-
ever, these previous studies did not use
the OGTT, and a signiﬁcant proportion
of cases are diagnosed on postload values
alone. Further, the role of measures of in-
sulin resistance and ectopic fat deposi-
tion, beyond abdominal fat, were not
explored, as we have performed here. In-
equalities in access to health care may ad-
versely affect risks of incident diabetes in
African Americans; this is not an issue in
the U.K., where health care is free at the
point of delivery. There are no previous
longitudinal studies comparing Indian
Asians with Europeans.
Direct measures of insulin sensitivity
are not feasible for epidemiological stud-
ies, which therefore need to rely on surro-
gates. There are many surrogates and no
clear consensus regarding which works
best. This reﬂects the choice of clamp
technique used, the population studied,
methods of validation used, and the pur-
pose of prediction. In general, surrogate
measures of IR that incorporate both
fasting and postload values are stronger
predictors of future diabetes than fasting
levels alone (15–17), although beyond
that the choice is less clear. Of the surro-
gates at our disposal, the Matsuda index
mappedmost closely to the ethnic/sex gra-
dient in diabetes incidence and provided
390 DIABETES CARE, VOLUME 36, FEBRUARY 2013 care.diabetesjournals.org
Ethnicity and incident diabetes
the most complete explanation for ethnic
differences in risk. Comparison of OGTT-
derived values of IR with hyperinsuline-
mic euglycemic clamp values suggests
that they are valid markers of clamp-
derived IR within Indian Asians (18) and
within people of Black African descent
(19), although these largely tested
HOMA and not Matsuda indices. Calcu-
lated b-cell function at baseline was partic-
ularly low in African Caribbean men and
lowest in those who had development of
diabetes during follow-up. It is tempting
to speculate that inadequateb-cell function
explains elevated postchallenge glucose in
African Caribbeans not matched by equiv-
alently elevated postload insulin. However,
smaller studies report C-peptide levels, a
direct measure of b-cell function, that are
similar in people of Black African descent in
the U.K., U.S., or Africa compared with
those of European origin; further, the
acute insulin response to a glucose load
is greater (20–22), even in those with es-
tablished diabetes (23). In African Carib-
beans, plasma insulin levels may be
particularly affected by reduced hepatic in-
sulin extraction and reduced insulin clear-
ance (20,22,24), which could explain
differences between variation inb-cell func-
tion and insulin concentrations. The path-
ogenesis of type 2 diabetes involves a
prolonged period of insulin resistance ini-
tially compensated by increasedb-cell func-
tion but latterly involving progressiveb-cell
deﬁcit (25). European and Asian Indian
men who would have development of
type 2 diabetes had relatively elevated
b-cell function, whereas among African Ca-
ribbeanmen andwomen there was no such
increase. These ﬁndings suggest differences
in the stage of pathogenesis reached in the
groups at baseline. Our ﬁndings imply that,
overall, IR was the principal driver of dia-
betes; however, in the absence of more de-
tailed evaluations of b-cell function, this
conclusion is tentative.
The greater visceral obesity of Indian
Asians is an obvious candidate to account
for the observed excess diabetes (26).
However, others have suggested that
deep subcutaneous truncal fat with larger
hypertrophic adipocytes may be of key
importance (27). We extend this observa-
tion by showing that truncal fat plays an
independent role in accounting for the
Indian Asian male excess in diabetes. Ad-
justment for truncal skinfolds provided
the most consistent attenuation in the
ethnic minority excess of diabetes inci-
dence for men and women (although
not independent of the Matsuda index
in the comparison between African Carib-
bean and European women). We conﬁrm
the excess truncal obesity in people of
Black African descent despite, in men at
least, less visceral fat (28), and its strong
predictive ability for diabetes incidence
(8). Excess truncal fat in both Indian Asians
and people of Black African descent is ob-
served in youth and, in both cases, the
growth trajectory for truncal skinfolds ap-
pears more rapid for the ethnic minority
groups (29,30). Whereas the greater trun-
cal fat despite less abdominal fat in women
has beenpreviously noted (31), it is striking
here that the sex difference in truncal obe-
sity is more marked in the ethnic minority
groups than in Europeans.
Adjustment for IR provided more
complete attenuation in the ethnic differ-
ence in diabetes incidence in women com-
pared with men. Others have reported sex
differences in response to the OGTT such
that, in some studies at least, women are
more likely to be classiﬁed as having
impaired glucose tolerance and men are
more likely to exhibit impaired fasting
glucose (32,33). Impaired fasting glucose
may be more strongly associated with
b-cell failure (33,34). Thus, the weaker
ability of HOMA-IR and Matsuda IR
indices to account for ethnic differences
in diabetes incidence in men may, specu-
latively, reﬂect the imprecision of their
characterization of b-cell function, which
may play a more important role in the
onset of diabetes in men.
Underlying explanations for the
greater predisposition to IR in people of
ethnic minority descent or, perhaps more
appropriately, the protection from IR in
individuals of European origin who, de-
spite escalating levels of obesity, remain at
lowest risk of diabetes are unknown.
Changes in fat distribution over the life-
course appear to differ by ethnicity
(29,30). Although a genetic susceptibility
may be an obvious explanation for ethnic
differences in metabolic and obesity char-
acteristics, and for the different trajectories
over the life-course, it is notable that total
energy intake is higher compared with Brit-
ish Europeans in largely ﬁrst-generation In-
dian Asian migrants to the U.K. (35) and in
Indian Asian children in the U.K. (36).
Within India, migrants from rural to urban
areas also have higher energy intakes com-
pared with those of the rural population
(37). This is associated with greater obesity,
ectopic fat distribution, and IR. Further, age-
related changes in adverse patterns of IR are
more marked in Indian Asian migrant pop-
ulations compared with Indian Asian
nonmigrant populations (35). Such rapid
changes inmetabolic characteristics are likely
to be environmentally rather than genetically
driven. It is notable that dietary intake com-
parisons between rural and urban Cameroo-
nians and British Jamaicans and Caribbeans
do not suggest greater calorie or saturated fat
intake in the latter (38); however, physical
activity levels have been shown to be lower
in migrant populations (39).
Strengths and limitations
To our knowledge, this is the largest
triethnic cohort in the U.K. with lengthy
(20-year) follow-up between middle and
older age, thus providing unique pro-
spective ethnicity-speciﬁc information on
diabetes incidence. Loss to direct follow-
up has occurred in one-third of all ethnic
groups. However, in sensitivity analyses,
the addition of hospital discharge (HES)
data to those from direct follow-up pro-
vides diabetes status formore than 91% of
traced individuals. Results of analyses
based on these more complete data were
similar to analyses based on direct follow-
up. Baseline measurements are limited to
those performed on only one occasion 20
years ago, meaning that we cannot ac-
count for changes in risk factors during
the follow-up period or in earlier life. We
have addressed lifestyle and socioeco-
nomic status using the available baseline
data on smoking habits, physical activity,
years of education, and occupational sta-
tus, but we acknowledge that these can-
not capture all the complexities of the
nonmetabolic explanations for ethnic dif-
ferentials in diabetes incidence.
In conclusion, Indian Asian and Afri-
can Caribbean migrants to the U.K. have
at least twice the risk of development of
diabetes compared with British Europe-
ans, even in older age, broadly reﬂecting
patterns observed in younger populations
worldwide. Given the increasing life ex-
pectancies for those with type 2 diabetes
(40), this presents a public health chal-
lenge. Measures of insulin resistance and
ectopic fat deposition, particularly trun-
cal, account for excess diabetes risk in In-
dian Asian and African Caribbean women
but only make a contribution to the
excess risk in ethnic minority men. Strik-
ingly, we show that despite our compre-
hensive measures, the ethnic minority
excess of incident diabetes in men (both
Indian Asians and African Caribbeans)
cannot be explained, whereas it can be
explained for women.We would have an-
ticipated otherwise, and our ﬁndings in
a different geographical setting than the
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U.S. and in two different ethnic groups
strongly indicate that better assessment
of risk factors and/or a search for novel
factors are required if we are to under-
stand why ethnic minority groups are at
such high risk for diabetes.
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